Fig. 10.
Fig. 10. Cell adhesion inhibition and the anti-Duva+antibody. / (A) CHO cells expressing the Duva+ form of the complex were incubated with the anti-Duva+ (open bar) or a control (gray bar) sera. Washed cells were then layered onto immobilized fibrinogen (250 ng per well) for 2 hours at 37°C. Quantification of bound cells was performed as described in the legend to Figure 7. (B) CHO cells expressing the Duva+ form of the complex were incubated with RGDS (open bar) or a control RGES (gray bar) peptides prior to adding 10 μL anti-Duva+ sera corresponding to a half-saturation amount. After a washing, bound human antibodies were detected by flow cytometry as described in the legend to Figure 3. Results represent the mean ± SD of 3 experiments.

Cell adhesion inhibition and the anti-Duva+antibody.

(A) CHO cells expressing the Duva+ form of the complex were incubated with the anti-Duva+ (open bar) or a control (gray bar) sera. Washed cells were then layered onto immobilized fibrinogen (250 ng per well) for 2 hours at 37°C. Quantification of bound cells was performed as described in the legend to Figure 7. (B) CHO cells expressing the Duva+ form of the complex were incubated with RGDS (open bar) or a control RGES (gray bar) peptides prior to adding 10 μL anti-Duva+ sera corresponding to a half-saturation amount. After a washing, bound human antibodies were detected by flow cytometry as described in the legend to Figure 3. Results represent the mean ± SD of 3 experiments.

Close Modal

or Create an Account

Close Modal
Close Modal